We are live on ! Find out more
CA

Centerpoint Advisors Portfolio holdings

AUM $307M
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+19.69%
3 Year Est. Return
+61.2%
5 Year Est. Return
+68.15%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$10.1M
Cap. Flow
-$4.9M
Cap. Flow %
-1.7%
Top 10 Hldgs %
66.82%
Holding
500
New
47
Increased
57
Reduced
79
Closed
18

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$659K
2
AAPL icon
Apple
AAPL
+$210K
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$141K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$113K
5
JEPQ icon
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
+$42.4K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.11M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$743K
3
NVDA icon
NVIDIA
NVDA
+$679K
4
JNJ icon
Johnson & Johnson
JNJ
+$520K
5
IWB icon
iShares Russell 1000 ETF
IWB
+$266K

Sector Composition

Rank Sector Weight
1 Technology 10.12%
2 Communication Services 4.2%
3 Healthcare 3.74%
4 Financials 2.72%
5 Consumer Discretionary 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHEL icon
276
Shell
SHEL
$254B
$20K 0.01%
300
– –
TRU icon
277
TransUnion
TRU
$15.1B
$20K 0.01%
190
-41
-18% -$3.7K
WCC
278
WESCO International
WCC
$16.7B
$20K 0.01%
119
– –
BMY icon
279
Bristol-Myers Squibb
BMY
$133B
$19K 0.01%
375
– –
BR icon
280
Broadridge
BR
$17.8B
$19K 0.01%
89
-19
-18% -$3.97K
DPZ icon
281
Domino's
DPZ
$11.5B
$19K 0.01%
44
– –
EXEL icon
282
Exelixis
EXEL
$13.3B
$19K 0.01%
+750
New +$18.6K
JPST icon
283
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$19K 0.01%
374
+205
+121% +$10.4K
NXST icon
284
Nexstar Media Group
NXST
$5.82B
$19K 0.01%
112
+23
+26% +$3.89K
PB icon
285
Prosperity Bancshares
PB
$8.97B
$19K 0.01%
270
– –
TTEK icon
286
Tetra Tech
TTEK
$8.49B
$19K 0.01%
405
-175
-30% -$7.79K
UFPI icon
287
UFP Industries
UFPI
$4.9B
$19K 0.01%
142
– –
UNF icon
288
Unifirst Corp
UNF
$5.3B
$19K 0.01%
94
+19
+25% +$3.5K
APOG icon
289
Apogee Enterprises
APOG
$826M
$18K 0.01%
+250
New +$16.1K
BC icon
290
Brunswick
BC
$5.13B
$18K 0.01%
217
– –
CGNX icon
291
Cognex
CGNX
$10.9B
$18K 0.01%
443
– –
CUBE icon
292
CubeSmart
CUBE
$9.39B
$18K 0.01%
342
– –
JKHY icon
293
Jack Henry & Associates
JKHY
$10.9B
$18K 0.01%
101
– –
KLIC icon
294
Kulicke & Soffa
KLIC
$4.67B
$18K 0.01%
395
+69
+21% +$3.05K
LH icon
295
Labcorp
LH
$25B
$18K 0.01%
+80
New +$17.6K
LSTR icon
296
Landstar System
LSTR
$5.93B
$18K 0.01%
97
– –
MRVL icon
297
Marvell Technology
MRVL
$168B
$18K 0.01%
250
– –
NDSN icon
298
Nordson
NDSN
$16.6B
$18K 0.01%
70
– –
NOG icon
299
Northern Oil and Gas
NOG
$2.3B
$18K 0.01%
513
– –
SEE
300
DELISTED
Sealed Air
SEE
$18K 0.01%
488
– –
10 11
12
13 14

Similar funds

TFA
TPG Financial Advisors Portland, Oregon $307M AUM 12.5% 1-Year Est. Return
ITB
Idaho Trust Bank Boise, Idaho $308M AUM 14.24% 1-Year Est. Return
HKIM
Hayek Kallen Investment Management Fairhope, Alabama $307M AUM 18.5% 1-Year Est. Return
ICP
Islander Capital Partners San Francisco, California $308M AUM
PC
Pecaut & Co Sioux City, Iowa $308M AUM 15.9% 1-Year Est. Return
AC
Alfreton Capital Radlett, Hertfordshire, United Kingdom $308M AUM 10.23% 1-Year Est. Return
EWM
Elite Wealth Management Kirkland, Washington $308M AUM 30.88% 1-Year Est. Return
BBWA
Bell & Brown Wealth Advisors Newport Beach, California $308M AUM 36.32% 1-Year Est. Return

Centerpoint Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Centerpoint Advisors held 500 positions worth $288M, up 3.6% from $278M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Centerpoint Advisors's Q3 2024 filing shows 47 new, 57 increased, 79 reduced and 18 closed positions. Its largest new stake was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K. The largest sale was Eli Lilly, an estimated $1.11M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Communication Services and Healthcare.

  • Centerpoint Advisors's largest Q3 2024 buy was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K.
  • Centerpoint Advisors added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $659K increase.
  • Centerpoint Advisors's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.11M.
  • Centerpoint Advisors fully exited Coca-Cola Femsa in Q3 2024, selling an estimated $96K.
  • Centerpoint Advisors's ten largest holdings make up 67% of its $288M portfolio in Q3 2024.
  • Centerpoint Advisors opened 47 new positions and closed 18 in Q3 2024.
  • Centerpoint Advisors's portfolio value rose 3.6% quarter-over-quarter to $288M.

Based on Centerpoint Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.